Physician profile
Ann E Podrasky
NPI 1336122233
$7,014.36
in general payments reported to CMS, 2019-2025
5 companies · $2,619 in 2025
The $2,619 reported for 2025 was more than what 92% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $84.12 · 2021: $160 · 2022: $242 · 2023: $246 · 2024: $2,770 · 2025: $2,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,500 · Food and Beverage: $1,022 · Travel and Lodging: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,500.00 |
| Food and Beverage | $1,022.08 |
| Travel and Lodging | $113.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $6,096.66 | 2019-2025 | Diagnostic Ultrasound System, General Device(S), Ct Scanner |
| Siemens Medical Solutions USA, INC. | $771.03 | 2019-2024 | Mammomat B.Brilliant, Biograph Vision 600 (8 Ring/64 Ct), Acuson Redwood Diagnostic Ultrasound System |
| Canon Medical Systems Corporation | $113.00 | 2024 | |
| Ge Healthcare | $33.67 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$434,273.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Podrasky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.